Healthcare tech and services company Bravado Health has named Mallory Tai Taylor CEO.
Ms. Taylor will serve as CEO of Bravado spinoffs ScriptRx and TreatRx, as well as Bravado. She previously served as COO and CFO of all three entities. She assumed the role of CEO on Aug.1, succeeding Chris Lazzara, according to an Aug. 3 news release from Bravado.
"I am honored to have been elected as Bravado Health's next CEO. It is a privilege to be part of an organization that delivers innovative healthcare solutions with such high-quality service to the best clients and helps to develop the most talented professionals into leaders," said Ms. Taylor.